This undated image provided by Merck on Friday, Oct. 5, 2018 shows a vial and packaging for the Gardasil 9 vaccine. On Friday, Oct. 5, 2018, the U.S. Food and Drug Administration expanded the use of the company's cervical cancer vaccine to adults up to age 45. (Merck via AP)